Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | PER3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | SETBP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | NPM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | VASH1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | EIF5AL1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | TCF4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | UBTF | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | GOT2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | B3GAT1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |